BioStock: Iconovo’s ICOcap inhaler receives CE marking

Iconovo’s strong start to 2020 shows no signs of slowing down as we approach summer. The company just added a CE marking to the list of reached milestones, making the company’s capsule-based dry powder inhaler ICOcap authorized for use in clinical trials by European customers. BioStock takes a closer look.

Read the full article at biostock.se:

https://www.biostock.se/en/iconovos-icocap-inhaler-receives-ce-marking/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se